Stereotaxis Inc Stock Nasdaq
Stocks
US85916J1025
Advanced Medical Equipment & Technology
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 08-11 | Stereotaxis, Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 08-11 | Stereotaxis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 139M 120M 113M 103M 193M 13.16B 193M 1.33B 517M 6.74B 523M 512M 21.76B | P/E 2026 * |
-6.84x | P/E 2027 * | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 139M 120M 113M 103M 193M 13.16B 193M 1.33B 517M 6.74B 523M 512M 21.76B | EV / Sales 2026 * |
4.06x | EV / Sales 2027 * | 3.05x |
| Free-Float |
78.85% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Stereotaxis Inc
| Manager | Title | Age | Since |
|---|---|---|---|
David Fischel
CEO | Chief Executive Officer | - | 2017-02-02 |
Kimberly Peery
DFI | Director of Finance/CFO | 57 | 2019-09-30 |
Keith Galloway
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Benfer
BRD | Director/Board Member | 79 | 2005-01-31 |
David Fischel
CHM | Chairman | - | 2017-02-02 |
Arun Menawat
BRD | Director/Board Member | 71 | 2016-09-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.75% | -1.35% | +24.60% | +13.24% | 227B | |
| -1.60% | -3.89% | +3.72% | -20.39% | 146B | |
| -0.85% | -1.58% | -21.45% | +19.18% | 130B | |
| +1.81% | +2.05% | -55.42% | -10.32% | 69.27B | |
| +0.13% | -0.34% | +11.07% | +18.34% | 51.82B | |
| +0.49% | -1.32% | -17.44% | -13.87% | 50.45B | |
| +0.59% | -1.94% | +17.17% | +27.06% | 42.53B | |
| -1.01% | -1.28% | +33.64% | +48.14% | 40.22B | |
| -1.55% | +1.22% | +120.58% | +36.88% | 32.95B | |
| Average | -0.30% | -1.56% | +12.94% | +13.14% | 87.75B | |
| Weighted average by Cap. | -0.54% | -1.55% | +6.66% | +8.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 34.33M 29.57M 27.81M 25.4M 47.5M 3.24B 47.65M 328M 127M 1.66B 129M 126M 5.36B | 45.67M 39.33M 36.99M 33.79M 63.18M 4.31B 63.38M 437M 169M 2.21B 171M 168M 7.13B |
| Net income | -20.13M -17.34M -16.31M -14.9M -27.86M -1.9B -27.94M -192M -74.68M -974M -75.6M -73.95M -3.14B | -14.77M -12.72M -11.96M -10.93M -20.43M -1.4B -20.5M -141M -54.78M -715M -55.45M -54.24M -2.31B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
